| DoD Awards $2.2B Contract for Molnupiravir Antiviral to Merck Sharp & Dohme LLC | Department of Defense | $2.2B | N/A |
| Merck Sharp & Dohme received $1.48B for VFC vaccine in 2014, a definitive con... | Department of Health and Human Services | $1.5B | N/A |
| HHS awarded Merck $1.45B for vaccines, with 7 bids received under full and op... | Department of Health and Human Services | $1.5B | N/A |
| HHS awards $1.37B contract for childhood vaccines to Merck Sharp & Dohme LLC | Department of Health and Human Services | $1.4B | N/A |
| HHS awards $236M contract to Merck for Biotechnology R&D, spanning 10 years. | Department of Health and Human Services | $236.3M | N/A |
| HHS awards $15.6M contract for ERVEBO procurement to Merck Sharp & Dohme LLC. | Department of Health and Human Services | $155.8M | N/A |
| ADDRESSING THE COVID-19 PANDEMIC: URGENT PRIORITIES | Department of Health and Human Services | $102.3M | N/A |
| HHS awarded $77.9M R&D contract to Merck Sharp & Dohme for unspecified resear... | Department of Health and Human Services | $77.9M | N/A |
| HHS Awards $65.1M for Ebola Vaccine Development to Merck Sharp & Dohme LLC | Department of Health and Human Services | $65.1M | N/A |
| Merck Sharp & Dohme LLC awarded $29.5M contract for adult vaccines by HHS. | Department of Health and Human Services | $29.5M | N/A |
| HHS awards $23.9M contract for adult vaccines to Merck Sharp & Dohme LLC | Department of Health and Human Services | $24.0M | N/A |
| Merck Sharp & Dohme received $23.2M for adult vaccines in 2013, a definitive ... | Department of Health and Human Services | $23.2M | N/A |
| HHS Awards $6.4M for Vaccine Storage and Rotation to Merck Sharp & Dohme LLC ... | Department of Health and Human Services | $6.4M | N/A |